Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on Aug 24, 2024 9:25am
199 Views
Post# 36194537

RE:RE:In the pipeline...

RE:RE:In the pipeline...Thanks StevenBirch...

-The fact that TLT is preparing for the future is a good indication that TLT management believe they have a great future.
-TLT not preparing for the future, would show investors(present and future) a big lack of vision on the part of TLT management.

In short...TLT preparing for the future is very reassuring.

I love the future of TLT.

StevenBirch wrote: Wildbird you have always seen the big picture. Yes the news releases have a de-risking effect and represent future value whereas the PP's determine the current value. So even with the news and the warrant expiry we are mired here until this PP closes, at least, and it will depend on how much they bring in. If there is a sense that this is the last one before BTD is granted then we should see some rise in the share price and hopefully a spike when it does come. And the future looks huge for those with the patience to hang around.



wildbird1 wrote: Some people on this board did mention that with the large number of pressrelease talking about the impressive number of new applications for TLT compounds, that they were surprised that the SP didn't go up.

Maybe it is because the goal of these Pressrelease was not a short term goal, but instead a long term goal.

With these Pressrelease TLT is preparing the future.
When TLT will finally become a big player in the field of cancer treatments(and they will), big investors will be coming on board. These big investors will want to know what is in the future for TLT. Why?..Because these big investors do not care about short term goals. No! they only care about long terms goals.
When these big investors will start buying, you can bet your shirt that the SP will start a steady climb, and will continue to climb with every new big investors coming on board.

Every big company has a pipeline section, were new investors can see what the future look like.

Judging by the big numbers of new future applications that TLT has, TLT pipeline is already quite impressive.

I love the future of TLT.




<< Previous
Bullboard Posts
Next >>